Podchaser Logo
Home
Helping patients know their risks of health issues

Helping patients know their risks of health issues

Released Sunday, 14th May 2023
Good episode? Give it some love!
Helping patients know their risks of health issues

Helping patients know their risks of health issues

Helping patients know their risks of health issues

Helping patients know their risks of health issues

Sunday, 14th May 2023
Good episode? Give it some love!
Rate Episode

Episode Transcript

Transcripts are displayed as originally observed. Some content, including advertisements may have changed.

Use Ctrl + F to search

0:00

Good afternoon. Thank you for joining us. Tarah Schwartz is off this week. I'm

0:01

Kelly Albert, and this is Health

0:04

Matters on CJAD 800. On today's

0:04

show women from racialized

0:09

communities are at a higher risk

0:09

of dying from heart disease.

0:12

Later in the show, we speak with

0:12

the cardiologist from the MUHC

0:15

about her initiative to reduce

0:15

barriers to accessing health

0:18

care. And the Trottier Family

0:18

Foundation has made a

0:21

significant donation to help

0:21

champion a more

0:24

environmentally-friendly

0:24

hospital. But first, this past

0:27

Monday was World Ovarian Cancer

0:27

Day. The MUHC Foundation is

0:31

proud to support many doctors,

0:31

researchers and clinician

0:34

scientists at the MUHC and

0:34

RI-MUHC who are working to find

0:39

a way to diagnose ovarian cancer

0:39

at an earlier stage when it is

0:43

more treatable and find better

0:43

treatments for patients. On

0:47

World Ovarian Cancer Day, a team

0:47

of dedicated volunteers joined

0:50

us for a thank-a-than; a time

0:50

where we could thank our

0:53

community for their support of

0:53

ovarian cancer research and

0:56

patient care. Valerie Aitken is

0:56

one of those dedicated

0:59

volunteers. She has been an

0:59

incredible supporter of the MUHC

1:02

Foundation, and she joins me

1:02

now. Hello, Valerie.

1:05

Hello, Kelly.

1:05

Speak to us this morning.

1:08

Nice to speak with

1:08

you too. We see each other at

1:11

events every once in a while.

1:11

And I just would love to know

1:14

how long have you been

1:14

volunteering with the MUHC

1:17

Foundation?

1:18

My diagnosis

1:18

with ovarian cancer was in 2015

1:23

and I went through the chemo,

1:23

the surgery. Actually in April

1:31

the next year, I said, how do I

1:31

give back? And I asked to speak

1:35

to somebody at the MUHC

1:35

Foundation to inquire as to how

1:43

that could happen.

1:45

That's incredible.

1:45

And it's been ever since. So

1:47

ever since 2016, you've been

1:47

volunteering with us?

1:51

Yes. And I think

1:51

also I was invited to the

1:55

breakfasts, which explained how

1:55

people can not only give money

2:01

in cash, but give shares, and

2:01

all the all the pros and cons of

2:06

that. So it was besides living

2:06

with ovarian cancer, I always

2:11

call it my journey. I don't call

2:11

it a struggle, whatever; it's a

2:15

journey. I learned more, I

2:15

became more financially

2:20

literate, which I thought was

2:20

for me, I always have to look at

2:25

the positive side. If something

2:25

happens, where are we going to

2:29

go. And for me, it's been able

2:29

to support Dr. Gilbert with the

2:33

award. So that is one of the

2:33

things I have been doing.

2:37

I really do admire

2:37

that because I think oftentimes

2:41

when we're faced with a

2:41

diagnosis, it can be very scary.

2:44

It can be a very overwhelming

2:44

time. But I feel that you have

2:49

really made it your mission to

2:49

look at it in a bright way and

2:54

know that you can change the

2:54

world by making these steps to

2:58

make your life more positive.

3:01

Yes, and also,

3:01

of course the people. The first

3:05

award I gave was given to a

3:05

biomedical engineer, and she is

3:09

still my friend. She is

3:09

responsible for part of the

3:13

little brush that's used in the

3:13

clinical trial. And then my

3:18

second award went to help a

3:18

nurse. She'd always already

3:22

registered nurse, but it helped

3:22

her get her master's degree in

3:25

epidemiology. And this is

3:25

somebody else who I've been in

3:30

touch with. And that also is

3:30

wonderful for me to see how

3:36

these people have contributed

3:36

towards Dr. Gilbert's trial.

3:41

Absolutely. So the

3:41

awards that we're speaking about

3:44

is the Valerie Jasset and Gary

3:44

Aitken Cancer Research Award,

3:47

and this goes towards the DOvEE

3:47

Project. We have spoken about

3:51

the DOvEE Project before on the

3:51

show. But for those who don't

3:53

know, it's a project from Dr.

3:53

Lucy Gilbert, which the goal is

3:57

to be like a Pap test for

3:57

ovarian and endometrial cancer.

4:02

The struggle with these cancers

4:02

is they're diagnosed usually at

4:06

a later stage, when it is very

4:06

difficult to treat. And the

4:10

DOvEEgene test, which was

4:10

created right here in Montreal,

4:13

the goal is to have a test so we

4:13

can detect these cancers earlier

4:17

and treat them at an earlier

4:17

stage. And this research awards

4:20

that you created, the amount

4:20

goes directly to Dr. Gilbert who

4:25

helps select a health care

4:25

worker who wants to make a

4:28

difference and is helping to make a difference. Is that correct?

4:31

That's correct.

4:31

Yes, if she has a need, then she

4:38

can use the money. So it's held

4:38

with the MUHC Foundation. I

4:43

think last year's award has not

4:43

been given yet because she's

4:46

looking for the right person to

4:46

give that money to.

4:50

Incredible. We're

4:50

in conversation with Valerie

4:53

Aitken, who is one of the

4:53

dedicated volunteers at MUHC

4:56

Foundation. She's a really

4:56

important part of our community.

4:59

And so you mentioned you are one

4:59

of Dr. Gilbert's patients. You

5:03

mentioned that you've been

5:03

working with the MUHC Foundation

5:05

quite a bit. Why is it important

5:05

for you to support both Dr.

5:09

Gilbert in the DOvEE Project,

5:09

and also just support excellence

5:13

in health care?

5:19

Obviously, I

5:19

spend quite a lot of time back

5:23

and forth between the hospital,

5:23

the clinics and the various

5:25

things. I think for me

5:25

supporting specifically the

5:33

research into ovarian cancer,

5:33

and to look and see how it can

5:39

be found before it becomes stage

5:39

two, stage three, stage four. As

5:48

you mentioned, are so more

5:48

difficult to treat. And with the

5:52

treatment, I have side effects.

5:52

So I am reminded every day, that

5:57

if it hadn't been for Lucy

5:57

Gilbert and her team, then I may

6:03

not be having this conversation

6:03

with you today. But I think this

6:10

is what I want to do. I want to

6:10

have women, particularly younger

6:18

women, this disease can be

6:18

caught nipped in the bud, and

6:24

then they would have a much

6:24

better quality of life. Quality

6:31

of life is what I see. The

6:31

little things that all these

6:36

treatments leave one with.

6:36

Myself, I want to live my life

6:45

as positively and as actively as

6:45

I can, but there are certain

6:51

things that slow you down,

6:51

because of the treatments. So

6:56

that's why my first donations.

6:56

Mind you, I am followed in two

7:05

other particular clinics, and I

7:05

do give money as well towards

7:10

that particular area of

7:10

medicine.

7:17

It's important to

7:17

give back for sure. In

7:19

conversation with Valerie

7:19

Aitken, who is a donor in our

7:22

community, she's a valued

7:22

volunteer of our community.

7:25

We're running short on time,

7:25

Valerie, but I did want to ask

7:28

you, we talk quite a bit about

7:28

giving back. We talk quite a bit

7:33

about philanthropy. What message

7:33

would you have for our listeners

7:37

about the importance of giving

7:37

back; particularly to a cause as

7:41

important as yours, as important

7:41

as the DOvEE Project, and why

7:46

you feel so connected to it?

7:47

Yeah, I think

7:47

people will say to me, I can't

7:50

give very much and perhaps,

7:50

giving $5 a month. Maybe you're

7:58

going to give up that $5 coffee.

7:58

And that's a way of saying, I

8:03

can do this and it's only a

8:03

little amount. But if everybody

8:07

gives a little amount, then I

8:07

see that as a way. It makes me

8:12

feel good when I'm giving

8:12

whether giving of myself or even

8:16

being able to give the award. So

8:16

at that would be my message.

8:20

That's a lovely

8:20

message. And as you mentioned,

8:23

you know, we have a lot of

8:23

information on our website about

8:26

the financial benefits that come

8:26

from it. There's taxable

8:29

benefits that come from this.

8:29

You can become more financially

8:31

literate when you know about the

8:31

different ways to give. And I

8:35

think you're right, any amount,

8:35

no matter the size of the amount

8:39

is an important demonstration

8:39

that you believe in the cause

8:42

and you believe in our

8:42

community. So thank you so much

8:45

for everything that you do for

8:45

us, Valerie. I really appreciate

8:47

your time today. That is Valerie

8:47

Aitken, one of our dedicated

8:52

volunteers and wonderful

8:52

supporters at the MUHC

8:54

Foundation. Next on Health

8:54

Matters, a donation in support

8:58

of making the many surgeries at

8:58

the MUHC more

9:01

environmentally-friendly. Tarah

9:01

Schwartz is off this week. I'm

9:05

Kelly Albert, welcome back to

9:05

Health Matters on CJAD 800. The

9:09

MUHC Foundation is proud to work

9:09

with a number of other

9:12

foundations who support our

9:12

Dream Big campaign and our goal

9:15

to provide excellent patient

9:15

care and push the boundaries

9:18

forward for innovative research

9:18

to find better treatments. The

9:21

Trottier Family Foundation has

9:21

been an important partner and

9:25

has recently donated $280,000 in

9:25

support of a project to reduce

9:29

the environmental impact of

9:29

anesthetic gases. You might know

9:33

that most surgeries are

9:33

performed with anesthetic gases.

9:36

Eric St-Pierre is the Executive

9:36

Director of the Trottier Family

9:39

Foundation and he joins me now

9:39

to talk about this wonderful

9:42

project. Hello, Eric.

9:43

Hi, Kelly. How are you?

9:44

I'm very well, thank you so much for being here. For those who don't know,

9:46

can you tell me a little bit

9:51

about the Trottier Family Foundation?

9:53

Absolutely. So

9:53

the Trottier Family Foundation

9:55

was established by Lorne

9:55

Trottier and Louise Rousselle

9:57

Trottier back in 2006. It was

9:57

created to create a meaningful

10:02

impact to improve the lives of

10:02

Canadians. And so we've had

10:05

about four main programs. So

10:05

we've been focusing a lot on

10:08

science, a lot on education,

10:08

climate change and health

10:12

sectors. For example, we're

10:12

currently at the Climate Summit,

10:17

which has been hosted in the Old

10:17

Port; in partnership with the

10:21

Montreal Climate Partnership.

10:21

And we're currently trying to

10:23

mobilize diverse stakeholders

10:23

around climate change. So I

10:27

would say Trottier Foundation

10:27

has become one of the largest

10:29

Quebec or Canadian funders, and

10:29

one of the biggest funders on

10:33

climate change.

10:35

Absolutely. And

10:35

so, why was it important for you

10:38

to support this project at the

10:38

MUHC- the hospital is already

10:42

eco-friendly, but to make it

10:42

even more eco-friendly?

10:45

Yeah, that's a

10:45

great question. So we started

10:48

analyzing what we could do with

10:48

our health program that might be

10:52

a little bit more proactive, and

10:52

a little bit more innovative,

10:56

and how can we address systemic

10:56

issues. We started realizing

10:59

that often health care is

10:59

treated separately from climate

11:03

change, or climate change is

11:03

treated separately from health.

11:07

But we realized they're actually

11:07

interconnected. They intersect

11:10

and overlap. For example, about

11:10

5% of emissions come from the

11:15

health and hospital sector. So

11:15

this might include buildings

11:19

that are heated on fossil fuels.

11:19

It might include large fleets of

11:22

vehicles, or think of

11:22

ambulances. But it also might

11:26

include things like food waste,

11:26

material supplies, or even

11:30

different gases. Hospitals and

11:30

the health sector is actually a

11:34

very significant emitter of CO2.

11:34

And last year, at the Climate

11:38

Summit, we had that Dr. Steven

11:38

Williams, who's a doctor at the

11:42

CHUM. And the CHUM announced

11:42

that they would go carbon

11:45

neutral by 2040. And this doctor

11:45

had announced a new method for

11:50

reducing emissions from

11:50

anesthetic gases by over 80%. So

11:55

it was sort of an innovative

11:55

first time that Quebec hospital

11:59

was doing something innovative

11:59

and reducing emissions and

12:03

gases. And so we quickly had a

12:03

conversation with the MUHC and

12:07

we thought, wouldn't this be

12:07

great if the MUHC was to become

12:10

the second hospital in Quebec to

12:10

also reduce emissions, and

12:14

anesthetic gases. We had the

12:14

MUHC very willingly contribute.

12:19

We're in conversation with Eric St-Pierre, who's the Executive

12:21

Director of the Trottier Family

12:23

Foundation, the foundation has

12:23

made a donation to the MUHC

12:27

Foundation for $280,000 to

12:27

support a make the MUHC greener

12:33

initiative. And this project,

12:33

particularly, as Eric mentioned,

12:37

pertains to anesthetic gases. So

12:37

I'll give a bit of background on

12:40

anesthetic gases; about 5% of

12:40

the gases used during surgical

12:44

procedures are the ones that are

12:44

absorbed into the body. So 95%

12:49

of the gases are released

12:49

through ventilation systems into

12:52

the environment. So this project

12:52

will help recuperate these gases

12:58

that are released into the

12:58

environment, and then use them

13:01

again, in a way that... I don't

13:01

know the science behind it, but

13:06

I know that they're able to

13:06

recuperate it to make them

13:08

usable again. So it's really

13:08

special, that it's so

13:13

innovative. And it really shows

13:13

forward thinking. Is that

13:16

important to have this

13:16

forward-thinking, innovative,

13:20

outside the box approach to

13:20

finding solutions?

13:23

Yeah, absolutely. I think the challenge is that the health

13:25

sector is so preoccupied with

13:29

significant health issues. We

13:29

just came out of COVID, or we're

13:32

still coming out of COVID. So

13:32

there's very significant issues.

13:37

And it's hard to make

13:37

connections to the climate

13:41

change, whether how we're

13:41

adapting to climate change, what

13:45

the impact of heat waves or

13:45

flooding on Montreal's

13:48

vulnerable populations. But also

13:48

how do we start reducing

13:51

emissions. So we're actually

13:51

starting to see some leadership

13:54

amongst some health institutions

13:54

that are really starting to

13:58

think about those innovative

13:58

ways to directly reduce

14:01

emissions. We're quite inspired

14:01

by this. And we actually think

14:05

that we should be trying to

14:05

scale this across the province.

14:08

We've got now a second hospital

14:08

that's reducing its gases. But

14:11

we'd love to see this spread

14:11

throughout the rest of the

14:13

province, ideally,

14:15

How does that

14:15

happen? Because I think it's

14:18

really difficult. I mean,

14:18

there's so many hospitals in

14:21

Montreal, of varying ages as

14:21

well. We're fortunate that the

14:25

MUHC is a relatively new

14:25

hospital as is the CHUM. And so

14:29

is it conversations? Is it going

14:29

to government officials? Is it a

14:33

little bit of everything?

14:35

Yeah, it's a little bit of everything. So what we're seeing is leadership.

14:37

We're seeing some hospitals,

14:41

being bold and acting as those

14:41

pilot projects and being the

14:45

early adopters, if you will. And

14:45

but what we really need to do

14:48

now is we need to take that

14:48

leadership and we need to start

14:52

putting it to scale. And that

14:52

will actually involve

14:57

conversations with the Quebec

14:57

government and other

15:00

stakeholders as well,

15:00

potentially City of Montreal,

15:04

health officials. We really need

15:04

to start having some

15:07

higher-level conversations with

15:07

the governments and public

15:11

policymakers to really advance

15:11

the discussion of the

15:14

intersection of health and climate.

15:17

We're in conversation with Eric St-Pierre, who is the Executive

15:19

Director of the Trottier Family

15:21

Foundation. What I really admire

15:21

about foundation supporting

15:26

other foundations is it shows

15:26

that we have one goal in mind.

15:32

It's to improve our community

15:32

improve our province, our city,

15:36

our country. And when we support

15:36

each other, I think it just

15:40

shows how important our impact

15:40

can be. And so I love asking the

15:45

guests that come on the show

15:45

with a philanthropic mind; what

15:49

is your message to listeners

15:49

about the importance of the

15:53

impact of philanthropy and

15:53

giving back? Regardless of the

15:57

size of donation, how important

15:57

is giving back?

16:00

Yeah, getting

16:00

back is crucial. For foundations

16:04

like us, philanthropic dollars

16:04

are still very meaningful. The

16:08

grants we're providing are

16:08

helping benefit hospitals in the

16:13

health sector. But it's actually

16:13

very small compared to what

16:16

governments have. And so our

16:16

support from the Trottier

16:20

Foundation, and I would

16:20

encourage other foundations in

16:23

the Montreal area, to really

16:23

look at their funding as being

16:27

catalytic, being bold and

16:27

innovative. So our hope is

16:31

actually that we may mobilize

16:31

other like-minded foundations to

16:35

start thinking about the links

16:35

between climate and health,

16:38

whether that's reducing

16:38

emissions in the health sector,

16:40

or helping vulnerable

16:40

communities adapt to the impacts

16:43

of climate change. I think it's

16:43

a call to action, if you will;

16:48

for funders to start thinking a

16:48

little bit differently.

16:52

For the average

16:52

person to, I think there might

16:55

be a sort of misconception that

16:55

I don't have a lot of money. We

16:59

all experience financial

16:59

insecurity sometimes, and it can

17:02

be difficult to give back. But

17:02

truly, the impact of every

17:06

dollar is really, really

17:06

significant, isn't it?

17:10

Yeah, absolutely. Every dollar works and has an impact. But everybody

17:12

has also a voice, right? So

17:16

everybody could put pressure on

17:16

their local hospital or if they

17:21

have elected officials, they can

17:21

they can contact their local MP

17:26

or local politicians to really

17:26

ask them- what are you doing for

17:29

climate? And what are you doing

17:29

for decarbonizing the health

17:32

sector, for example? There's a

17:32

lot of tools and toolbox for

17:35

everybody.

17:36

Yeah, I love that

17:36

idea. I think we don't

17:38

necessarily always associate

17:38

giving back with time, like

17:41

volunteering or making calls or

17:41

really using your voice to push

17:46

forward to cause it is important

17:46

to you. So I think that's a

17:48

really excellent point.

17:50

We all have to

17:50

try our best and all hands on

17:52

deck, as they say.

17:54

Well, Eric, thank you so much for coming on the show. We really appreciate it.

17:55

And as I mentioned, this

17:59

donation is really going to help

17:59

push forward a more eco-friendly

18:02

hospital and really continue to

18:02

make the MUHC as green as

18:05

possible.

18:06

Thank you, Kelly. I really appreciate being on.

18:08

That is Eric St. Pierre, the executive director of the Trottier Family

18:10

Foundation, the foundation made

18:12

a $280,000 donation to a project

18:12

that will help recuperate

18:17

anesthetic gases and make a less

18:17

environmental impact. Coming up

18:21

on Health Matters, an historic

18:21

discovery that changed how to

18:24

know who is more at risk for

18:24

breast cancer and the local

18:28

researcher who helped make it

18:28

happen. Tarah Schwartz is off

18:31

this week. I'm Kelly Albert, and

18:31

this is Health Matters. The

18:34

BRCA1 and BRCA2 are two genes

18:34

that impact a person's chances

18:39

of developing breast cancer. You

18:39

might have heard of the BRCA

18:42

gene from celebrity news,

18:42

Angelina Jolie decided to have a

18:46

preventative double mastectomy

18:46

after finding she was a carrier

18:49

of the BRCA1 gene. This

18:49

discovery was first reported in

18:53

1994, and one of the scientists

18:53

at the RI-MUHC was part of the

18:58

team that discovered these genes

18:58

and has helped push forward

19:01

research to whom it impacts. Dr.

19:01

Patricia Tonin is a senior

19:04

scientist in the Cancer Research

19:04

Program at the RI-MUHC, she was

19:08

part of the team who discovered

19:08

the gene and joins me now.

19:11

Hello, Dr. Tonin. Hello, thank

19:11

you so much for being here.

19:15

Thank you for having me.

19:17

In very general

19:17

terms, for those who may not

19:19

know what the BRCA1 and BRCA2

19:19

genes are, can you describe them

19:26

to me?

19:26

Yes. So

19:26

these are genes that code for

19:29

proteins that are involved in

19:29

the normal functioning of our

19:35

cells. All of our cells in our

19:35

body have this, we all inherit

19:39

these genes from our parents. We

19:39

have two copies of them, one

19:44

that we inherit from our mothers

19:44

when we inherit from our

19:47

fathers. And what they produce

19:47

are proteins that are important

19:53

to maintain what we call the

19:53

integrity of DNA in the cells.

19:59

Okay, so sometimes

19:59

the cells change or aren't the

20:07

way that they're supposed to be,

20:07

and that impacts your health?

20:10

Yes. So

20:10

what's interesting about these

20:13

two genes is that if you inherit

20:13

a very variant in these genes,

20:21

which we call pathogenic. In

20:21

other words, if you inherited a

20:24

variant that's not a normal

20:24

variant, that would have no

20:28

consequence. But it's something

20:28

that would change the

20:32

functioning of the protein that

20:32

it makes. This results in one of

20:38

two things, either the protein

20:38

that's made is not functioning

20:41

properly, or it's just simply

20:41

not making a protein at all. So

20:45

what happens is that you can

20:45

inherit this variant from either

20:51

parent. And if you do inherit

20:51

it, it significantly increases a

20:57

woman's chance of developing

20:57

breast cancer and ovarian

21:02

cancer. For men, it increases

21:02

could increase your risk for

21:07

developing breast cancer and

21:07

prostate cancer. Depending on

21:12

what gene is involved.

21:14

Wow. And so this

21:14

is a historic discovery, for

21:19

many reasons, but because it

21:19

really helps pinpoint who's more

21:22

at risk of developing these

21:22

cancers.

21:25

Absolutely.

21:25

So they can be used as what we

21:28

call biomarkers. So we knew that

21:28

carriers of either of these

21:33

variants, they develop breast

21:33

cancer on average at a younger

21:37

age. Before the age of 50,

21:37

sometimes as young as in their

21:42

mid-30s. They can develop

21:42

ovarian cancer; perhaps not as

21:47

young but still ovarian cancer

21:47

is quite a deadly disease. The

21:52

risk for developing ovarian

21:52

cancer is lower than the risk

21:55

for breast cancer, but it's

21:55

still a real risk. And because

21:59

the ways in which to treat

21:59

ovarian cancer are not as

22:02

sophisticated as they are for

22:02

breast cancer, it's possible

22:06

that it can be lethal. We now

22:06

know, through years of research

22:11

that men who carry mutations in

22:11

BRCA1 or BRCA2 are at an

22:18

increased risk for breast cancer

22:18

as well. The risk is not the

22:22

same as for women, but it's

22:22

there. And for BRCA2, the most

22:28

important observation is that if

22:28

they carry mutation and they

22:34

develop prostate cancer, it can

22:34

be quite lethal. So the

22:38

management is quite different

22:38

now for men who have prostate

22:43

cancer, and it's known that they

22:43

carry a mutation in one of these

22:47

genes.

22:48

It's really, really fascinating. We're in conversation with Dr. Patricia

22:50

Tonin, a senior scientist in the

22:53

Cancer Research Program at the

22:53

RI-MUHC. So you are one of the

22:57

scientists who was part of the

22:57

team that made this discovery in

23:00

1994. If you could take us back

23:00

to those years. Did you know

23:06

that what you were working on

23:06

was going to be as

23:10

transformative- I guess is the

23:10

word- as it was?

23:13

Yes, yes,

23:13

definitely. Because the way in

23:17

which we found both BRCA1 and

23:17

reported it in the scientific

23:22

literature into the world in

23:22

1994. And then BRCA2, about a

23:26

year later, it was just after

23:26

the holidays, in December of

23:35

1995. We knew then, that it

23:35

would be impactful. What we

23:42

studied were families that had a

23:42

large number of breast cancer

23:46

cases in them, or ovarian

23:46

cancers and breast cancers. We

23:51

knew that the ages of diagnosis

23:51

of breast cancer were young.

23:54

It's the genetic study of these

23:54

families, which led us to

23:58

pinpoint exactly where in the

23:58

human genome these two genes are

24:02

located. So we had genetic

24:02

markers that we knew we're

24:10

tracking in the families, but we

24:10

couldn't find a gene. Until we

24:14

performed some genetic tests,

24:14

which allowed us to pinpoint

24:17

exactly where these genes were.

24:17

And that's the role that I

24:20

played it for BRCA1 and then for

24:20

BRCA2. By pinpointing where to

24:27

look for the genes, it allowed

24:27

our colleagues elsewhere to

24:31

physically clone the genes. Then

24:31

through DNA sequencing, we're

24:35

able to show the link between

24:35

having a variant in one of these

24:40

genes and the gene itself. Then

24:40

itself becomes a marker which

24:47

then can be used to identify all

24:47

the members of the family. Do

24:51

they contain the same variant or

24:51

not? Because everything is

24:55

hereditary, if it is passed from

24:55

one generation to the next. It's

24:59

not what we called de novo, it's

24:59

not something new. It's

25:02

something that's in your family

25:02

and your family history; it

25:04

could be there for hundreds of

25:04

years. And that reveals itself

25:08

when cancer presents itself.

25:08

Perhaps at an unusually younger

25:13

age, or when you have a lot of

25:13

siblings, or close family

25:18

members that have the disease.

25:18

That's how it reveals itself.

25:22

And it becomes a marker for

25:22

family history of disease and

25:26

for the risk.

25:28

Absolutely. And

25:28

that's how your research is

25:30

continuing. You started

25:30

examining the French Canadian

25:32

population

25:33

yes...

25:34

For these markers

25:34

as well. And we're short on

25:37

time. But can you tell us very

25:37

briefly about what your findings

25:40

were in the French Canadian population?

25:42

Yes, we

25:42

published a paper in 1998,

25:44

showing that women who had

25:44

family histories of breast and

25:54

ovarian cancer had very specific

25:54

mutations in either BRCA1 or

26:00

BRCA2 that were tracked in

26:00

individual families. And the

26:03

significance of this at that

26:03

time, was that it provided a way

26:10

to specifically use these as

26:10

genetic markers for finding

26:17

women and men in the population

26:17

who carry these variants, which

26:21

can then be used for genetic

26:21

counseling purposes. So these

26:25

genes, both genes are very, very

26:25

large. They're very complex

26:29

mutations or variants that can

26:29

occur anywhere in the gene. And

26:32

it made it very difficult to

26:32

find the underlying causal

26:37

variant. In specific

26:37

populations, like the French

26:41

Canadians, which can trace their

26:41

ancestors back to common

26:45

founders. They could have

26:45

inherited the same variant in

26:49

their families for generations,

26:49

tracing back to the 1600s. So we

26:54

were able to find those specific

26:54

variants. And at the time the

26:57

discovery was made was

26:57

important, because it allowed us

27:00

to provide a more precise

27:00

genetic counseling advice to

27:05

individuals who may carry these

27:05

mutations. Because sometimes the

27:09

precision was just not there

27:09

with sequencing. Now we have

27:13

sophisticated sequencing methods

27:13

where we can look at the entire

27:17

gene, but back then it was

27:17

costly, it was not necessarily

27:20

available to everyone. And this

27:20

was one way to be able to reach

27:25

a much larger population, as we

27:25

did with the Ashkenazi Jewish

27:32

population, we offered that as

27:32

well. Now we offer genetic

27:35

testing to everyone who is

27:35

eligible for testing.

27:38

It's incredible

27:38

the advances that have been able

27:41

to be made as a part of this

27:41

discovering, because of

27:44

improvements in technology. We

27:44

just have 45 seconds left, Dr.

27:48

Tonin. But you recently were

27:48

part of the team recognized for

27:52

the BRCA1 and 2 gene discovery.

27:52

You received a plaque in London

27:59

at the Cancer Research Institute

27:59

in London. There's a plaque with

28:04

your name as part of the team

28:04

that made this discovery. How

28:06

special is that honor?

28:08

Just to

28:08

clarify that plaque specifically

28:10

for BRCA2 and not for BRCA1

28:10

because those are two separate

28:15

discoveries, same people. So the

28:15

question is, how does it make me

28:19

feel?

28:20

Yes, how is it to

28:20

be recognized that way?

28:23

Fantastic,

28:23

because the purpose behind this

28:28

plaque is what it contains is

28:28

the order of all the authors

28:31

that published the seminal paper

28:31

on the discovery of BRCA2. The

28:37

purpose behind these plaques,

28:37

that are that are on the

28:40

buildings of these Cancer

28:40

Institute's is to recognize team

28:44

science. In other words, is to

28:44

recognize how many people are

28:50

involved to get to the point

28:50

where we can answer a question.

28:56

Rarely are teams recognized.

28:56

Usually, these are individuals.

29:03

It could be the lead author of

29:03

paper or the leader of the team.

29:06

But in reality, when you pull

29:06

the curtain back and you look at

29:10

what's happening in a lab,

29:10

there's a large number of people

29:13

from graduate student trainees,

29:13

undergraduate students, all the

29:17

way up to the team leaders. And

29:17

then this is replicated across

29:22

many, many labs. To be able to

29:22

achieve the successes that we

29:27

were able to achieve as a group

29:27

with the discoveries of these

29:30

two genes is an example of this.

29:30

It required the study of

29:34

geneticists, molecular

29:34

biologists, biologists, breast

29:39

cancer and ovarian cancer and

29:39

prostate cancer specialists from

29:42

around the world to come

29:42

together to be able to do this.

29:46

I could not have been done with

29:46

one particular group or one

29:50

particular team or one

29:50

particular method, it required

29:54

interdisciplinary effort to be

29:54

able to come to this point. And

30:00

the field that I'm in, also

30:00

continues to operate in that way

30:06

and operates quite successfully.

30:06

I mean, there are other genes

30:09

that have been discovered over

30:09

the past 20 years that are also

30:13

known to increased risk for

30:13

breast and ovarian cancer. So

30:17

it's not just those two genes.

30:17

There's now up to 13 different

30:20

genes that have been identified,

30:20

that will allow us to provide

30:28

advice for carriers and what to

30:28

do.

30:30

It's really

30:30

remarkable, and we're so excited

30:33

to have you at the RI-MUHC

30:33

continuing to push the needle

30:36

forward with your research. Dr.

30:36

Tonin, congratulations on this

30:39

recognition. And thank you so

30:39

much for joining us on the show.

30:42

Thank you. Thank you.

30:43

That's Dr. Patricia Tonin, a senior scientist in the Cancer Research

30:44

Program at the RI-MUHC. Coming

30:48

up next on Health Matters, women

30:48

from racialized communities are

30:51

at a higher risk of dying from

30:51

heart disease. Learn how a team

30:54

of doctors at the MUHC want to

30:54

reduce the barriers to accessing

30:58

care. Tarah Schwartz is off this

30:58

week. I'm Kelly Albert and

31:00

you're listening to Health

31:00

Matters. The leading cause of

31:03

death for women in Canada is

31:03

heart disease and cases are

31:06

rising every year. For women in

31:06

racialized communities, the

31:09

rates are even higher. There are

31:09

many reasons why this is

31:12

happening from limited access to

31:12

cardiovascular specialists to

31:15

risks of being overlooked. But

31:15

Dr. Judy Luu hopes to correct

31:19

this with the creation of POWER

31:19

Hub. It's an initiative at the

31:23

MUHC. Cardiologist Dr. Judy Luu

31:23

joins me now to discuss Good

31:25

afternoon, Dr. Luu.

31:27

Hi, good afternoon, Kelly, thank you for having me.

31:30

Thank you so much

31:30

for being here. So do you think

31:32

the average person; and in

31:32

particular, the average woman

31:35

knows their risks of heart

31:35

disease?

31:39

That's an

31:39

excellent question. So we have

31:42

contemporary research to show

31:42

that the average woman actually

31:46

doesn't recognize that heart

31:46

disease is the number one

31:49

killer. So research from the

31:49

United States, which is our

31:51

close neighbor shows that only

31:51

about half a woman recognize

31:55

this very fact. So it definitely

31:55

suggests that there's a lack of

31:58

awareness among a significant

31:58

proportion of women about the

32:01

risk of heart disease. There's

32:01

lots of reasons why this may be.

32:04

I mean, on top of having

32:04

traditional cardiovascular risk

32:07

factors like high blood

32:07

pressure, high cholesterol,

32:10

diabetes, and obesity, a lot of

32:10

women don't know that these risk

32:14

factors impact them much more

32:14

than they do a man. So for

32:17

instance, a woman with diabetes

32:17

is three times more likely to

32:21

die from heart disease when

32:21

compared to a man. So this

32:25

information is currently not

32:25

that fully obvious in the

32:30

public. And so a lot of women do

32:30

underestimate the risk when it

32:33

comes to heart disease.

32:34

Those are really

32:34

big numbers. And, you know,

32:36

we're speaking more specifically

32:36

about women in racialized

32:38

communities. So how much higher

32:38

is that that risk for women in

32:42

racialized communities?

32:46

For Canadian data,

32:46

we don't have an exact number,

32:49

per se. But we do now recognize

32:49

that, racial and ethnic

32:54

disparities do exist when it

32:54

comes to the occurrence of heart

32:58

disease and the outcomes of

32:58

heart disease. And so what do I

33:00

mean by that? For example, from

33:00

the Heart and Stroke Foundation

33:04

of Canada, we know that

33:04

indigenous women do face a

33:09

higher risk of heart disease and

33:09

stroke. And this is due to a

33:11

number of things that are very

33:11

complex. And I want to caveat

33:15

that there's a lot of factors

33:15

like socio-economic factors,

33:20

employment, education, access to

33:20

health services, nutritious

33:23

foods, adequate housing, so all

33:23

of these can impact racialized

33:28

communities and heart disease.

33:28

Indigenous people are just one

33:32

of them. But there's also other

33:32

examples across the multi ethnic

33:36

spectrum. South Asian

33:36

populations in Canada, also have

33:40

higher proportions of heart

33:40

disease. They've shown again, in

33:44

Heart and Stroke, that South

33:44

Asian people oftentimes have up

33:48

to 10 years earlier, chances of

33:48

having heart disease compared to

33:53

their white counterparts. So all

33:53

in all, I say there, again, I

33:58

want to caveat that there's a

33:58

lot of health disparities. And

34:00

the situation is very complex

34:00

and multifaceted. And what I

34:03

mean by multifaceted is there's

34:03

like systemic reasons, societal,

34:07

and health-related reasons. And

34:07

we're only really beginning to

34:10

understand that we're at the

34:10

very tip of this iceberg in

34:13

trying to help resolve this

34:13

current situation.

34:17

Of course, I mean,

34:17

whether it be socio-economic

34:21

factors, as you mentioned, it

34:21

could there could be a variety

34:24

of reasons why this is happening. But it's important to know that it is happening and

34:25

that it's a problem that we can

34:28

try to help with. We're in

34:28

conversation with Dr. Judy Luu,

34:32

a cardiologist at the MUHC, so

34:32

you want to start an initiative

34:36

called POWER. So it's Pathway to

34:36

Cardiovascular Care for Women in

34:41

Ethnic, Racialized and Remote

34:41

Communities. POWER- I really

34:44

liked that acronym. So tell us

34:44

about the POWER Hub and your

34:47

idea behind it.

34:49

Yes. Thank you so much for this opportunity to talk about the POWER Hub. It

34:51

really came as a call to action

34:55

as a national initiative for

34:55

some research funding. When I

35:02

conceptualize the idea; as a

35:02

team of clinicians, researchers,

35:07

women who have lived experience,

35:07

and other community members, we

35:09

definitely recognize that there

35:09

are several deep layers of

35:13

barriers that exist when we come

35:13

to providing equitable care for

35:18

a woman, especially in our

35:18

province in Quebec. And what I

35:22

mean by these barriers are

35:22

things that are including,

35:25

access to specialists, even just

35:25

cultural awareness and

35:29

sensitivities about heart

35:29

disease. There's also a

35:32

physician-patient language

35:32

discordance, especially someone

35:35

doesn't speak English, or if

35:35

they don't speak French in our

35:38

province. And then importantly,

35:38

really systematically we're

35:43

poorly underestimating the risk

35:43

profile of a woman. And so

35:49

that's how the POWER Hub came to

35:49

be. As a new

35:53

clinician-scientist, physician,

35:53

a woman's heart health

35:55

cardiologist at MUHC, I wanted

35:55

to form this network of

36:03

powerhouse team members to

36:03

really bridge the gap between

36:07

the French and the English

36:07

health care system. And to find

36:11

a way how we can redefine how

36:11

cardiovascular care is delivered

36:15

for women in Quebec. So, very

36:15

briefly to the podcast is

36:21

limited. But briefly, the POWER

36:21

Hub is a virtual network that

36:27

comprises of multiple sites

36:27

throughout Quebec. It includes

36:29

the CHUM that includes like

36:29

physician numbers and

36:32

researchers from the CHUM; as

36:32

well as, Laval. And our other

36:36

international collaborators from

36:36

the US including Cedar Sinai in

36:39

Los Angeles. And this POWER Hub

36:39

is designed to co-develop and

36:46

create with our community

36:46

members. So we have the Jamaica

36:54

Association in Montreal, too.

36:54

And the vision really is to

36:57

create a platform where all key

36:57

stakeholders can really work

37:02

together to understand what the

37:02

disparities and health

37:05

disparities are, and to find

37:05

meaningful and effective ways to

37:10

improve those disparities and

37:10

better deliver access to care

37:14

for a woman in Quebec.

37:16

I find it so

37:16

important and inspiring that

37:19

you're working with the

37:19

community stakeholders. Because

37:21

there's so many different groups

37:21

in Montreal that maybe don't

37:25

feel represented in health care

37:25

and for a variety of reasons.

37:29

But I think it's really, really

37:29

wonderful that you're working

37:31

together with these different groups to make sure that everyone feels supported.

37:36

100%, and one of

37:36

our main tripartite leadership

37:40

members is like I said is the

37:40

Jamaica Association but they

37:42

have access to all the other

37:42

black communities in the City of

37:46

Montreal. I think it's very important for us to reach out to. We're in our infancy and

37:48

trying to really garner those

37:54

relationships with these

37:54

cultural and ethnic community

37:56

associations. So eventually, we

37:56

will reach out to, let's say,

37:59

the Iranian community, the Greek

37:59

communities, and so many other

38:03

the Chinese, Vietnamese etc. And

38:03

so it's important for us to

38:07

really build those relationships

38:07

as they help us in the

38:11

fundamental creation of all

38:11

these deliverables of the POWER

38:15

Hub.

38:16

It's really

38:16

inspiring to hear and I know

38:18

that the foundation is

38:18

supporting you through this

38:21

initiative, and we want to get

38:21

you funding to help expand this

38:24

program and get this program off

38:24

the ground. So I'm really

38:26

grateful to have a cardiologist

38:26

like you who's working so

38:29

diligently to help make sure

38:29

that we have full representation

38:32

and equity in health care. Thank

38:32

you so much, Dr. Luu.

38:35

Thank you.

38:36

That is Dr. Judy

38:36

Luu, a cardiologist and one of

38:39

the team members behind the

38:39

POWER Hub and initiative here at

38:43

the MUHC that hopes to bring

38:43

cardiovascular care to women in

38:46

racialized communities. I'm

38:46

Kelly Albert, thank you for

38:49

tuning in. What would you like

38:49

to hear about on the show? Write

38:52

to me at healthmatters at

38:52

MUHCFoundation.com. You can also

38:56

follow the MUHC Foundation on

38:56

social media or sign up for our

39:00

newsletter at our website,

39:00

MUHCFoundation.com. Tarah will

39:03

be back next Sunday. Thank you

39:03

for listening to Health Matters

39:06

and stay healthy.

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features